Stay updated on Amivantamab SC in Advanced Solid Malignancies Clinical Trial
Sign up to get notified when there's something new on the Amivantamab SC in Advanced Solid Malignancies Clinical Trial page.

Latest updates to the Amivantamab SC in Advanced Solid Malignancies Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA centralized 'Locations' section is added listing study sites in California, Indiana, New York, Oregon, Tennessee, and Ontario, with the previous separate location sections removed.SummaryDifference0.7%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdministrative updates were made to reflect the new study record entries for 2025-12-04 and 2025-12-05, and older 2025-11 entries were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page shows a revision update from v3.2.0 to v3.3.2 with no evident changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page now displays a 'Last Update Posted (Estimated)' line, and a banner regarding government funding status has been removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check55 days agoChange DetectedEnrollment changed from an estimated 192 participants to an actual 158 participants. The Last Update Posted date was updated to a more recent timestamp (from 2025-10-09 estimated to 2025-11-06 actual).SummaryDifference0.4%

- Check62 days agoChange DetectedNo additions or deletions were detected; the page content remains focused on the study details, eligibility criteria, and locations.SummaryDifference0.4%

Stay in the know with updates to Amivantamab SC in Advanced Solid Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab SC in Advanced Solid Malignancies Clinical Trial page.